EcoDrugPlus

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSAPEG00000010026
Gene Symbol: ENPP2
1 Cross references
226 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSAPEG00000024153
Gene Symbol: EGLN1
1 Cross references
216 Possible Orthologues:

Egl-9 Family Hypoxia-Inducible Factor 3

Ensembl ID : ENSAPEG00000000070
Gene Symbol: EGLN3
1 Cross references
196 Possible Orthologues:

Egl-9 Family Hypoxia-Inducible Factor 3

Ensembl ID : ENSAPEG00000013864
Gene Symbol: EGLN3
2 Cross references
195 Possible Orthologues:

Endothelial Pas Domain Protein 1b

Ensembl ID : ENSAPEG00000012454
Gene Symbol: EPAS1B
1 Cross references
212 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSAPEG00000019405
Gene Symbol: ECE1
1 Cross references
231 Possible Orthologues:

Endothelin Receptor Type Aa

Ensembl ID : ENSAPEG00000023965
Gene Symbol: EDNRAA
1 Cross references
205 Possible Orthologues:

Endothelin Receptor Type Ab

Ensembl ID : ENSAPEG00000013882
Gene Symbol: EDNRAB
1 Cross references
201 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSAPEG00000023924
Gene Symbol: EDNRB
1 Cross references
200 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSAPEG00000022287
Gene Symbol: EDNRB
1 Cross references
178 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSAPEG00000003874
Gene Symbol: EZH2
1 Cross references
240 Possible Orthologues:

Eph Receptor B4b

Ensembl ID : ENSAPEG00000020980
Gene Symbol: EPHB4B
1 Cross references
167 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).